Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease. The progressive subtype of NAFLD or nonalcoholic steatohepatitits (NASH), may …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United
States. While the American Association for the Study of Liver Diseases guidelines define …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. The
prevalence in patients with type 2 diabetes mellitus is between 55–80%. The spectrum of …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
United States and many other parts of the world. Its prevalence continues to rise—currently …

It is estimated that 30% of the adult population in Japan is affected by nonalcoholic fatty liver
disease (NAFLD). Fatty changes of the liver are generally diagnosed using imaging …

Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease in the
United States, affecting up to 30% of adults. There are two forms of NAFLD: nonalcoholic …

Nonalcoholic fatty liver disease (NAFLD) ranges from simple hepatic steatosis to non-
alcoholic steatohepatitis (NASH) and cirrhosis. The majority of NAFLD patients do not …

Hepatic steatosis is the buildup of lipids within hepatocytes. It is the simplest stage in
nonalcoholic fatty liver disease (NAFLD). It occurs in approximately 30% of the general …

The spectrum of nonalcoholic fatty liver disease (NAFLD) ranges from asymptomatic
steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Hepatic steatosis occurs …

Background & Aims: This prospective study evaluates the role of radiological modalities in
establishing the diagnosis of nonalcoholic steatohepatitis (NASH). Methods: Consecutive …